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Measures to assess commonly experienced
symptoms for people with dementia in
long-term care settings: a systematic
review
Clare Ellis-Smith*, Catherine J. Evans, Anna E. Bone, Lesley A. Henson, Mendwas Dzingina, Pauline M. Kane,
Irene J. Higginson, Barbara A. Daveson and on behalf of BuildCARE
Abstract
Background: High symptom burden is common in long-term care residents with dementia and results in distress
and behavioral challenges if undetected. Physicians may have limited time to regularly examine all residents,
particularly those unable to self-report, and may rely on reports from caregivers who are frequently in a good
position to detect symptoms quickly. We aimed to identify proxy-completed assessment measures of symptoms
experienced by people with dementia, and critically appraise the psychometric properties and applicability for use
in long-term care settings by caregivers.
Methods: We searched Medline, EMBASE, PsycINFO, CINAHL and ASSIA from inception to 23 June 2015,
supplemented by citation and reference searches. The search strategy used a combination of terms: dementia
OR long-term care AND assessment AND symptoms (e.g. pain). Studies were included if they evaluated
psychometric properties of proxy-completed symptom assessment measures for people with dementia in any
setting or those of mixed cognitive abilities residing in long-term care settings. Measures were included if
they did not require clinical training, and used proxy-observed behaviors to support assessment in verbally
compromised people with dementia. Data were extracted on study setting and sample, measurement
properties and psychometric properties. Measures were independently evaluated by two investigators using
quality criteria for measurement properties, and evaluated for clinical applicability in long-term settings.
Results: Of the 19,942 studies identified, 40 studies evaluating 32 measures assessing pain (n = 12), oral health
(n = 2), multiple neuropsychiatric symptoms (n = 2), depression (n = 8), anxiety (n = 2), psychological wellbeing
(n = 4), and discomfort (n = 2) were included. The majority of studies (31/40) were conducted in long-term care
settings although none of the neuropsychiatric or anxiety measures were validated in this setting. The pain
assessments, PAINAD and PACSLAC had the strongest psychometric evidence. The oral health, discomfort, and
three psychological wellbeing measures were validated in this setting but require further psychometric evaluation.
Depression measures were poor at detecting depression in this population. All measures require further investigation
into agreement, responsiveness and interpretability.
Conclusions: Measures for pain are best developed for this population and setting. All other measures require further
validation. A multi-symptom measure to support comprehensive assessment and monitoring in this population is
required.
Keywords: Dementia, Long-term care, Palliative care, Review, Symptom assessment
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Background
People with dementia in long-term care settings com-
monly have high levels of comorbidity and symptom
burden [1]. Multiple symptoms at all stages of the
disease with varying prevalence are reported [1–9],
notably pain (12–76 %) [2], dyspnea (8–80 %) [2], de-
pression (9–32 %) [5, 7], anxiety (3–22 %) [5, 7], halluci-
nations (2–11 %) [5, 7], and delusions (18 %) [5].
Assessment is challenging, with declining verbal com-
munication and cognition and absence of biological
markers; with reliance on clinical examination. Untreated
symptoms lead to distress and behavioral complications
and compromises quality of life, resulting in challenges to
clinical management [10] and staff burden [11].
Caregivers providing personal care are well placed to
detect and monitor symptoms through daily contact and
knowledge of residents [12], and refer to physicians for
clinical examination and treatment. Routine use of mea-
sures in care supports systematic assessment and moni-
toring of symptoms, with increased access to treatment
and improved outcomes [13]. However, there is limited
evidence on their use in long-term care settings [13]. Re-
quirements for such measures are that they are valid and
reliable to ensure accurate assessment, responsive to
change, clinically interpretable, brief and simple to use
[14], and require minimal training [15]. Additionally,
measures used by caregivers should not require a clinical
qualification or expertise, and should support assess-
ment through proxy-observed behaviors and signs for
those residents unable to reliably self-report.
Caregiver assessment in long-term care settings is not
well-established for all common symptoms, e.g. psych-
otic symptoms [16]. However, measures based on care-
giver knowledge of the person with dementia without
the requirement of clinical expertise, and validated in
other settings, may have clinical applicability in long-
term care settings and be transferable. With further
validation, psychometrically robust and established as-
sessment measures could support caregiver assessment
of residents in long-term care.
This systematic review aimed to identify proxy-
completed assessment measures of common symptoms
experienced by people with dementia, and critically
appraise the psychometric properties and applicability
for use in long-term care settings by caregivers.
Methods
This systematic review followed Preferred Reporting
Items for Systematic Reviews and Meta-Analyses
(PRISMA) (Additional file 1: PRISMA checklist) [17].
Search strategy
We searched Medline, EMBASE, PsycINFO, CINAHL
and ASSIA from inception to 9 April 2014 and updated
on 23 June 2015. A search strategy was developed, in-
formed by search strategies used in previous reviews,
and a scoping review of common symptoms in people
with dementia performed by the authors. A combination
of MeSH and keyword terms were used: dementia [18]
OR long-term care AND assessment AND symptoms [19]
(e.g. pain, dyspnea, depression, dental pain; Additional
file 2). The search was supplemented by reference
and citation search of included articles using Scopus.
Eligibility criteria
The population comprised people with dementia, or de-
mentia subgroup analyzed separately, in any care setting,
e.g. long-term care, inpatient hospital. All settings were
included to identify validated measures with potential
applicability to long-term care settings. To include mea-
sures with high applicability in long-term care, studies
with mixed cognitively intact and cognitively impaired
participants in these settings were included. Measures
were included if they assessed symptoms using proxy-
observed behaviors or signs in people whose verbal com-
munication was compromised due to dementia, were
validated in English, and were for use in routine care
without the requirement of formal clinical training.
Caregiver self-administered measures were included as
they do not rely on clinicians or trained personnel to
administer them, which reduces their applicability for
use in care. We excluded studies of:
 Measures that required verbal responses from
people with dementia
 Measures that were face-to-face or interview
administered to proxies due to limited clinical
applicability in routine care
 Behavioral measures that did not identify underlying
causes of behavioral change, for example, measures
of aggression and sleep disturbance
 Measures not primarily assessing symptoms,
including those of frailty, cognition, functioning,
disease progression, quality of life, and risk, and
process measures, e.g. quality of communication
 Measures that required extensive training that may
not be easily accessible or available to caregivers
Studies were identified for inclusion if they were in the
English language and evaluated at least two psychomet-
ric properties (including one aspect of reliability and
validity) of the full measure. Qualitative, review studies,
theses, and conference abstracts were excluded.
Study selection
One investigator (CES) reviewed titles and abstracts and
excluded all those clearly irrelevant. Full text review was
then conducted by one investigator (CES) to exclude
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those studies not meeting the inclusion criteria. Studies
not clearly excluded were reviewed by a second reviewer
(AEB) and the final inclusion of studies was agreed by
discussion and consensus. Where further information
was required to determine eligibility criteria, the authors
were contacted. When authors were not contactable, a
decision was made based on available information.
Data extraction and assessment of quality criteria of
measures
One reviewer (CES) extracted all data from each study
into a standardized data extraction Excel template, and
assessed the psychometric properties using quality
criteria for measurement properties of health status
questionnaires. Data extraction included (1) study set-
ting, sample, and who the measure was administered by;
(2) measurement properties, including method of ad-
ministration, number of items, rating period, time to ad-
minister, and training required; and (3) psychometric
properties, including content validity, internal consistency,
criterion validity, construct validity, reproducibility
(agreement and reliability), responsiveness, floor and
ceiling effects, and interpretability [20]. Where applic-
able, psychometric properties were extracted on de-
mentia subsamples. Evaluation of each psychometric
property was based on detailed and well-established
quality criteria [20], with four ratings: positive (strong
psychometric properties using adequate design and
method), intermediate (some but not all aspects of
property is positive, or there is doubt about design
and method used) [21], negative (psychometric property
does not meet criteria despite adequate design and
method), or no information. Details of methodological
and quality criteria are detailed in Terwee et al. [20] but
include, for example, requirement for formulated hypoth-
eses with 75 % of hypotheses supported by findings for
construct validity, intraclass correlation coefficient (ICC)
or Cohen’s kappa ≥0.70 for reliability, ≤15 % obtaining
highest or lowest possible scores for floor and ceiling ef-
fects, and sufficient sample size ≥50 for all (sub)groups.
As quality rating of sensitivity and specificity are not
included in the Terwee et al. [20] quality criteria, we
calculated the sum of percentages misclassified, i.e.
false positives and false negatives, as follows: [(1 –
sensitivity) + (1 – specificity)] [22] and gave a positive
rating for criterion validity of misclassification less
than 50 %, i.e. better than chance [23]. A second reviewer
(LAH, MD, or PMK) checked the data extraction and in-
dependently assessed the quality. The first and second re-
viewer resolved any disagreements by consensus. Where
authors did not state which aspect of validity or reliability
were being evaluated, the investigators made a judgement
based on the methods used.
Results
Study selection
A total of 28,386 studies were identified through data-
base searches. After deduplication, 19,942 titles and ab-
stracts were screened, of which 1,302 were retained for
full-text review. Following an independent review of 154
studies, 36 were retained for inclusion. Reasons for
exclusion were required verbal responses from person
with dementia (n = 125), face-to-face or interview ad-
ministered to proxy (n = 38), no symptom assessment
(n = 289), not dementia population (n = 64), not vali-
dated in English (n = 169), not or insufficient psycho-
metric evaluation (n = 374), dissertation/conference
abstract/study not published in English/other (n = 195),
and administration required extensive training (n = 12).
Following citation and reference searches, an additional
four studies were identified for inclusion, resulting in a
total of 40 studies (Fig. 1).
In total, 32 measures were identified, assessing pain
(n = 12), oral health signs and symptoms (n = 2), multiple
neuropsychiatric symptoms (n = 2), depression (n = 8),
anxiety (n = 2), psychological wellbeing (n = 4), and dis-
comfort (n = 2). The majority of studies were conducted
in long-term care settings (n = 31), with seven studies
recruiting from outpatient clinics [24–30]. One study was
conducted in an orthopedic ward [31] and one in psycho-
geriatric wards [32]. Only 11 out of the 40 studies in-
cluded measures administered by non-clinically trained
caregivers: six pain measures [33–39], two oral health
signs and symptoms measures [40, 41], two depression
measures [42, 43], and one psychological wellbeing meas-
ure [44]. The neuropsychiatric symptoms [26, 30] and
anxiety [24] measures were all validated with unpaid
caregiver proxies in community settings. Additional
file 3 provides setting and population details of each
study.
Quality assessment agreement between reviewers was
86 %. Disagreements were resolved by consensus, e.g.
data checking, and discussion regarding adequacy of
hypotheses and whether findings supported hypotheses.
The strength of the psychometric properties of measures
validated in long-term care settings
Of those measures validated in long-term care settings,
the measures with strongest psychometric properties for
pain were Pain Assessment in Advanced Dementia
(PAINAD) [31, 45–48], and Pain Assessment Checklist
for Seniors with Limited Ability to Communicate
(PACSLAC/PACSLAC-II) [35, 36, 45, 47, 49, 50]. The
Oral Health Assessment Tool (OHAT) [40] and Dis-
comfort Scale-Dementia Alzheimer’s Type (DS-DAT) [47,
51] had the strongest psychometric properties for oral
health and discomfort, respectively (Table 1). The depres-
sion measures demonstrated weak abilities to accurately
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detect depression in this population, and all the psycho-
logical wellbeing measures require further validation. No
measures achieved positive ratings for all psychometric
properties with information lacking on agreement, floor
and ceiling effects, responsiveness, and interpretability
(Additional file 4).
Measures were administered through observation dur-
ing provision of routine care, observations during speci-
fied activities or time periods, examinations, knowledge
of resident, all available information available to care-
giver, or video recordings of residents. Rating periods
ranged from one minute to one month, with time taken
to complete ranging from 30 seconds to 10 minutes.
Measurement training ranged from none to 4 hours
(where details were provided), and up to 2 days for val-
idation purposes. Table 2 summarizes the elements of
the measure (scoring, rating period), and the feasibility
(measure length, time to complete, training require-
ments) and applicability (method of administration used
in the included studies, type of training) of measures;
Additional file 5 provides details of all measures.
Pain
The measures identified to assess pain were the Abbey
Pain Scale (APS) [33, 47, 52], Checklist of Nonverbal
Pain Indicators (CNPI) [45, 46, 52, 53], CNA Pain
Assessment Tool [34], Doloplus-2 [52], Mahoney Pain
Scale [38], Non-communicative Patient’s Pain Assess-
ment Instrument (NOPPAIN) [45, 54], PAINAD [31,
45–48], PACSLAC [36, 45, 47, 49, 50] and PACSLAC-
II [35], Pain Assessment in Communicatively Impaired
[37, 50, 55], Pain Assessment for Dementing Elderly
(PADE) [39, 45], and Pain Behaviors for Osteoarthritis
Instrument for Cognitively Impaired Elders [29].
Of these, the PAINAD and PACSLAC have been
the most extensively evaluated with the strongest psy-
chometric properties. PAINAD has good internal
consistency (Cronbach’s alpha of 0.70 and greater)
[46, 47]. Inter-rater reliability is strong (kappa = 0.87
[45], ICC ≥0.87 [47]) in two studies, although one
study reported an ICC of 0.24 when administered in
rest situations and 0.80 during movement situations
[46]. PAINAD has demonstrated good construct valid-
ity against APS, PACSLAC, CNPI, NOPPAIN, and
PADE at rest and during exercise (r ≤0.62) [45, 47].
The PACSLAC demonstrated good construct validity
against the NOPPAIN, CNPI, PADE, APS, and PAINAD
at rest and during exercise (r ≤0.56) [45, 47]. Inter-rater
reliability at rest and movement situations is consistently
high (ICC ≥0.76) [45, 47, 50]. Both measures require
Fig. 1 PRISMA flow chart detailing search and reasons for study exclusion
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further validation when used by caregivers as these have
predominantly been evaluated when administered by
trained research assistants or clinicians. PACSLAC-II is a
modified and shortened version of the PACSLAC based
on theoretical and evidence developments in pain assess-
ment, and has good content validity [35]. Only one study
evaluating the psychometric properties of PACSLAC-II
[35] was identified, and was conducted in long-term care
settings and administered by trained research assistants
and caregivers. Evidence for construct validity was sup-
ported with expected strong correlations with PACSLAC,
CNPI, PADE, and PAINAD in pain and non-pain con-
ditions (r ≥0.56), and expected weak correlations with
the Cornell Scale for Depression in Dementia (CSDD)
(non-pain condition: r = –0.05, vaccination: r = 0.10,
movement: r = –0.06). PACSLAC-II demonstrated abil-
ity to discriminate between non-pain and painful con-
ditions (P <0.01). Internal consistency was strong
(Cronbach’s alpha ≥0.74) and interrater reliability
kappa was 0.63.
The NOPPAIN [45, 54] and CNA Pain Assessment
Tool [34] are the only measures of pain developed for
administration by non-clinically trained caregivers.
The NOPPAIN is completed by observations carried
out during routine care tasks, and is designed for easy
administration with limited training [54]. NOPPAIN has
high correlation (r ≤0.70) against CNPI, PACSLAC,
PADE, and PAINAD with an inter-rater reliability
kappa of 0.73 when administered by trained research
assistants [45].
Oral health signs and symptoms
Two measures, the Brief Oral Health Status Examination
(BOHSE) [41] and the OHAT [40], were identified. Both
assess oral health in long-term care residents and are ad-
ministered by caregivers through oral examination of the
resident. OHAT was derived from BOHSE and is sim-
pler. OHAT comprises eight items and involves 3 hours
of training to caregivers with calibration. When com-
pared against comprehensive examination by a dentist,
the Pearson correlation coefficients for each item ranged
from –0.1 to 1.0 (n = 21). Test-retest reliability item-
level unweighted kappa ranged from 0.51 to 0.71, with a
total score ICC of 0.78. Inter-rater reliability item-level
unweighted kappa ranged from 0.47 to 0.66 with a total
score ICC of 0.74 (n = 485). Further testing in a larger
sample is required to test validity.
Multiple neuropsychiatric symptoms
The Neuropsychiatric Inventory Questionnaire (NPI-Q)
[26] is an unpaid (usually family) caregiver self-admin-
istered version of the well-validated and extensively-used
NPI [56]. The NPI is sometimes reported as a behav-
ioral measure, but was included in this review as it
Table 1 Evaluation of quality criteria of measures with strongest psychometric properties validated in long-term care settings
Name of measure Content
validity
Internal
consistency
Criterion
validity
Construct
validity
Reproducibility Responsiveness Floor and
ceiling effects
Interpretability
Agreement Reliability
Pain
PAINAD [48] + ? 0 ? 0 ? 0 – ?
PAINAD [46] ? ? 0 ? 0 – 0 – 0
PAINAD [47] 0 + – + 0 + 0 0 ?
PAINAD [45] 0 ? ? + 0 + 0 0 0
PACSLAC [49] + ? 0 ? 0 0 0 0 0
PACSLAC [36] 0 0 ? ? 0 ? 0 0 0
PACSLAC [47] 0 ? – + 0 + 0 0 ?
PACSLAC [45] 0 ? ? + 0 + 0 0 0
PACSLAC [50] 0 0 – ? 0 + 0 0 0
PACSLAC-II [35] + ? 0 + 0 – 0 0 0
Oral health
OHAT [40] + 0 ? 0 0 + ? – 0
Discomfort
DS-DAT [51] + ? 0 ? 0 ? 0 0 0
DS-DAT [47] – – – + 0 + 0 0 ?
PAINAD, Pain Assessment in Advanced Dementia; PACSLAC, Pain Assessment Checklist for Seniors with Limited Ability to Communicate; OHAT, Oral Health
Assessment Tool; DS-DAT, Discomfort Scale for patients with Dementia of Alzheimer’s Type
+ A positive rating indicates strong psychometric properties according to quality criteria using adequate design and method [20]
? Intermediate [21] rating indicates some but not all aspects of psychometric properties are positive, or there is doubt about the design and method used [20]
– A negative rating indicates psychometric properties do not meet criteria despite adequate design and method used [20]
0 No information provided in the paper [14]
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Table 2 Summary of measure details, methods of administration, and feasibility and applicability in care
Measures Number of
items (range)
Scoring
(ranges)
Methods of
administration
Rating period Time to
compete
(range)
Training required
Pain APS 5–60 0–5 to
0–60
Observation over
specified time
period
1 minute specified
observation time,
observation during
specified activities,
observations during
all personal care
provision
30 seconds to
5–10 minutes
Most measures do
not require any formal
training Two have
been specifically
developed for non-
clinically trained
care staff
CNPI Observation during
specified activity
CPAT Observation during
routine care
Training for raters in
the studies ranged
from 5 minute training
video to 2 hours, or
continued training
throughout data
collection period
Doloplus-2 From memory based
on knowledge of
resident
MPS
NOPPAIN Ratings of video
recordings of
activities or pain
events
PAINAD Signs of pain
including facial,
behavioral, vocal,
functional
PACSLAC(-II)
PACI
PADE
PBOICIE
Oral health BOHSE 8–10 0–16 to
0–20
Observation and
examination
Examination period 6–8 minutes 3–4 hours of training,
with calibration
OHAT
Neuropsychiatric NPI-Q 12–81 0–36 Observation and
knowledge of person
Last 4 weeks 5 minutes None
CDBQ 0–248
Depression BDI-modified 7–21 0–15 to
0–80
Observation, all available
information sources,
knowledge of person
Last week to
last 4 weeks
No
information
No training, 30 minutes
training or provision
of instructions and
instruction manual
CESD-modified MDS coordinator
usually registered
nurseCSDD-modified/
CSDD-M-LTCS
DDMS
DSS
CS-GDS
Hayes and Lohse
Non-verbal
Depression Scale
MDSDRS
Anxiety GAI-modified 8–20 0–20 to
8–40
Modified to be
self–administered by
informal caregiver,
based on knowledge
of person
Last week No
information
None
PSWQ-A-
modified
Psychological
wellbeing
PGCARS 5–11 0–90 Observation 5 minutes to
last 24 hours
5–10 minutes Group and one-to-one
teaching sessions with
supervised practicePWB-CIP
AARS
AER
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assesses symptom experience, including depression,
anxiety, hallucinations and delusions, and provides
observational signs to support assessment of these
symptoms. The NPI-Q subscales demonstrated high cor-
relations with the original clinician-administered NPI sub-
scales (r <0.70, n = 60). The California Dementia Behavior
Questionnaire [30] was designed to assess behavior,
but was included in this review as the majority of
items assess the symptoms of depression and psych-
osis and is completed based on unpaid caregiver ob-
servations. Neither of these measures have been
validated in the long-term care setting.
Depression
Of the ten depression measures identified, two were
developed for the purpose of assessment of verbally
compromised people with dementia: the Minimum
Data Set Depression Rating Scale [57–60], and Hayse
and Lohse Non-Verbal Depression Scale [61]. The
former is a seven-item scale derived from Minimum
Data Set 2.0 items and developed to screen for de-
pression by caregiver staff drawing upon observations
during routine care; designed for long-term care set-
tings it has high clinical applicability and is the most
extensively psychometrically evaluated. However, evi-
dence for detecting depression against gold-standard
diagnosis of depression at a score cut-off point ≥3 is
mixed with sensitivities and specificities of 0.91/0.69
(40 % misclassified, n = 82) [58] and 0.23/0.97 (80 %
misclassified, n = 145) [57].
The CSDD is designed to be administered through
interview with the person with dementia and a proxy
but was modified for proxy-completion in two studies
[32, 43]. Watson et al. [43] modified the CSDD for use
by long-term caregiver staff most involved in the resi-
dent’s care using all available information to make the
assessment (CSDD-M-LTCS). Modifications involved
cognitive testing to remove technical language and
changing response options from severity to frequency.
Sensitivity and specificity against geriatric psychiatrist
diagnosis was 0.33/0.86 (81 % misclassified, n = 112).
Test-retest reliability was strong (≥0.70) but limited by
small sample size (ICC = 0.83, n = 25) and inter-rater
reliability ICC was 0.20 (n=111).
The Depression Signs Scale and Depression in Demen-
tia Mood Scale [32] were originally designed to be ad-
ministered based on clinical interview with the person
with dementia and information from proxies, but were
modified to be completed based on all available informa-
tion to psychogeriatric ward staff.
The Geriatric Depression Scale (GDS) [27, 28, 42], Beck
Depression Inventory [27], and Center for Epidemiologic
Studies Depression Scale [27] were not originally de-
veloped for dementia but have been used in this
population, either through clinical interview or self-report.
In the included studies, they have been modified for
proxy-completion by unpaid caregivers. The evidence for
validity and applicability for use in long-term care by care-
givers is therefore limited. One study examined caregiver-
completed Collateral Source-GDS (CS-GDS) 30 and 15
versions in long-term care compared to gold standard
Table 2 Summary of measure details, methods of administration, and feasibility and applicability in care (Continued)
Ratings of video
recordings
Training for raters in
the studies ranged
from none to 2 days
Discomfort DBS 9–17 0–17 to
0–102
Rated based on
information from
informants, observations
and resident interactions
Past week No
information
MDS coordinator,
usually registered nurse
DS-DAT
Observation over
specified period and
activity program
5 minute
observation
or specified
activity program
DS-DAT requires training
and may have limited
clinical applicability as
complex to learn
Training for raters
included continued
training throughout
data collection period
APS, Abbey Pain Scale; CNPI, Checklist of Nonverbal Behaviors; CPAT, CNA Pain Assessment Tool; MPS, Mahoney Pain Assessment Tool; NOPPAIN, Non-communicative
Patient’s Pain Assessment Instrument; PAINAD, Pain Assessment in Advanced Dementia; PACSLAC, Pain Assessment Checklist for Seniors with Limited Ability
to Communicate; PACI, Pain Assessment in Communicatively Impaired; PADE, Pain Assessment for Dementing Elderly; PBOICIE, Pain Behaviors for Osteoarthritis
Instrument for Cognitively Impaired Elders; BOHSE, Brief Oral Health Status Examination; OHAT, Oral Health Assessment Tool; NPI-Q, Neuropsychiatric Inventory
Questionnaire; CDBQ, California Dementia Behavior Questionnaire; BDI-modified, Beck Depression Inventory – modified; CESD-Modified, Center for Epidemiologic Studies
Depression Scale – modified; CSDD-modified, Cornell Scale for Depression in Dementia - modified; CSDD-M-LTCS, Cornell Scale for Depression in Dementia Modified for
use by Long Term Care Staff; DDMS-modified, Depression in Dementia Mood Scale – modified; DSS-modified, Depression Signs Scale – modified; GDS, Geriatric Depression
Scale; MDSDRS, Minimum Data Set Depression Rating Scale; GAI-modified, Geriatric Anxiety Inventory – modified; PSWQ-A-modified, Penn State Worry Questionnaire
– Abbreviated – modified; PGCARS, Philadelphia Geriatric Center Affect Rating Scale; PWB-CIP, Psychological Wellbeing in Cognitively Impaired Persons;
AARS, Apparent Affect Rating Scale; AER, Apparent Emotion Rating Instrument; DBS, Discomfort Behavior Scale; DS-DAT, Discomfort Scale for patients with
Dementia of Alzheimer’s Type; MDS, Minimum Data Set
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diagnosis of depression [42]. In the dementia subsample
(n = 35), sensitivities and specificities for the CS-GDS-30
and CS-GDS-15 were 0.70/0.56 (74 % misclassified) and
0.71/0.64 (66 % misclassified), respectively. Pearson correl-
ation coefficient between CS-GDS and GDS ranged from
0.50 to 0.61 [42].
Anxiety
Two anxiety measures, the Collateral-completed Geriatric
Anxiety Inventory and the Penn-State Worry Questionnaire-
Abbreviated were identified in the same study [24].
Both were modified in this study to be proxy-completed
by unpaid caregivers. Sensitivity and specificity for the two
measures, against gold-standard clinician-administered
MINI-International Neuropsychiatric Inventory [62], were
0.62/0.93 (45 % misclassified) and 0.81/0.73 (46 % misclas-
sified), respectively (n = 41). This study was not conducted
in long-term care settings and proxies were therefore not
caregiver staff. The measures’ validity and applicability in
this setting were therefore not established.
Psychological wellbeing
We identified four measures focused on psychological
wellbeing. These were Psychological Wellbeing in
Cognitively Impaired Persons [25], the Philadelphia
Geriatric Center Affect Rating Scale (PGCARS) [63],
Apparent Affect Rating Scale (AARS) [44], and the
Apparent Emotion Rating Instrument (AER) [64]. The
AARS and AER are both derived from PGCARS, origin-
ally developed by Lawton et al. [65]. However, this study
was not included due to extensive training over 1 month
provided to research assistant administrators [65].
The PGCARS, AARS, and AER were all validated in
nursing home settings, and AARS and AER were ad-
ministered by caregivers in the validation study. All
three measure positive and negative affect, including
items of pleasure, interest, anger, anxiety, and depression/
sadness. All these measures require further psychometric
evaluation.
Discomfort
The term discomfort is operationalized as the presence
of a negative emotional/physical state that can be ob-
served [51]. The Discomfort Behavior Scale (DBS) was
developed to assess discomfort/pain [66]; it was derived
from items on the Minimum Data Set 2.0 and it has
therefore been developed for use in long-term care. It is
administered based on review of all available informa-
tion, including direct observation and communication
with residents, discussions with family, and review of
records [66]. Internal consistency of DBS is positive
(Cronbach alpha = 0.77, n = 9,672) [66]. However, only
one psychometric evaluation of the DBS was identified
and further evaluation is warranted.
The DS-DAT [47, 51] does not require clinical train-
ing. Neither of the studies identified reported the re-
quirement for extensive training and DS-DAT was
therefore included in this review. DS-DAT has, however,
been critiqued as complex to use and requiring signifi-
cant training [67]. As such, it may not be useful as a
symptom assessment tool in routine care provision. It
has demonstrated expected high correlations with pain
assessment measures PAINAD, APS, and PACSLAC
(≥0.63) and a strong inter-rater reliability ICC at rest
(0.83) and exercise (0.85, n = 62) [47].
Discussion
Key findings
To our knowledge, this is the first systematic review to
identify and appraise assessment measures of symptoms
commonly experienced by people with dementia for use
in long-term care settings. Our review identified 32
proxy-completed measures of common symptoms expe-
rienced by people with dementia. Of these measures,
those that assess pain possess the strongest evidence of
psychometric properties. Progress on all the other mea-
sures is promising, although oral health, psychological
wellbeing, and discomfort measures require further psy-
chometric evaluation, and there have been challenges in
developing a measure that accurately detects depression.
Neither of the two neuropsychiatric or two anxiety mea-
sures were validated in the long-term care setting. Fur-
thermore, we found only 11 studies where measures
were validated when administered by non-clinically
trained caregivers even though these caregivers are fre-
quently in the best position to detect changes quickly
due to enhanced resident knowledge and contact [12].
Despite the extent of symptoms experienced by this
population, we were unable to find any multi-symptom
assessment measures validated for use in routine care as
an assessment measure. Instead, we found measures that
assess single symptoms or symptom groups, specifically
pain, oral health signs and symptoms, multiple neuro-
psychiatric symptoms, depression, anxiety and psycho-
logical wellbeing, and discomfort. Assessing discomfort
may alert caregivers to physical or emotional discomfort
that can then be further investigated to determine the
underlying cause [68]. However, content analyses of pain
and discomfort measures in dementia found significant
overlap resulting in poor sensitivity in assessing these
constructs [69], a finding supported by our results with
pain and discomfort frequently being used interchange-
ably. An alternative to assessing discomfort is to provide
caregivers with measures to assess all common symp-
toms. This would facilitate a comprehensive symptom
assessment, and alert caregivers to consider all common
symptoms and sources of distress.
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Caregivers’ use of a battery of single assessments (e.g.
pain, neuropsychiatric symptoms, oral health) could fa-
cilitate detection and monitoring of common symptoms,
but is unlikely to be feasible for regular and frequent use
due to the time taken to complete multiple measures.
Palliative or end-of-life measures, such as the Symptom
Management at the End of Life in Dementia [70] or the
Palliative care Outcome Scale [71] could provide a brief
yet comprehensive assessment of common physical, psy-
chological, and other distressing (such as agitation) [70]
symptoms to support detection and management of
symptoms in care. The former was developed to meas-
ure outcomes and evaluate end-of-life care in dementia
and has been extensively evaluated [70, 72–74], although
predominantly after the death of the resident. It incorpo-
rates nine symptoms in people dying with dementia and
therefore has the potential for use as a clinical assess-
ment measure for people in the dying phase. The
Palliative care Outcome Scale was developed for a non-
dementia population but has sound psychometric prop-
erties and is used across settings to support clinical care
[75]. It has been used to assess symptoms and the qual-
ity of palliative care to nursing home patients with and
without dementia [76] and found to have the potential
to identify areas of care that require addressing. None-
theless, there was a high level of missing scores for some
items (≤59.8 %) in the dementia subgroup, suggesting
adaptation is required for this population [76]. Results of
a qualitative study suggest that such multi-symptom
measures used in routine care may require provision of
proxy-observed behaviors or signs to assess verbally-
compromised residents with dementia [77]. Use of a sin-
gle multi-symptom measure may not provide a detailed
assessment of each symptom. However, multi-symptom
measures may support comprehensive assessment of
symptoms with minimal time burden and, if required,
inform requirement for further assessment or prompt
referral to health professionals.
The second major finding from our study is the lack
of assessment measures to assess common symptoms.
The clinical challenges and importance of accurately
assessing pain in this population is apparent by substan-
tial development in pain measures, evidenced by a re-
cent meta-review [78]. As a consequence, we found pain
measures have the strongest psychometric evidence.
Nonetheless, despite the prevalence of other common
symptoms in residents with dementia, such as nausea,
constipation, and dyspnea, we were unable to identify
any measures to assess these. With further evaluation,
the Respiratory Distress Observation Scale-Family
(RDOS-Family) [79] has potential to be an important
measure for detecting dyspnea in long-term care resi-
dents with dementia. The original RDOS was designed
for cognitively impaired adults unable to self-report
but required clinical expertise to administer [80].
RDOS-Family is family caregiver self-administered
based on observations with a 20-minute training pro-
vided. It has good inter-rater reliability (ICC = 0.71)
between family and trained research assistants when
used with patients hospitalized for conditions with
dyspnea.
The stringent methodological requirements of the
quality criteria and the challenges of conducting re-
search in verbally compromised people with dementia
resulted in no measures achieving positive ratings for all
psychometric properties in the review. In particular, this
review shows that detecting depression in people unable
to self-report in this setting is challenging and that
caregivers’ use of observational signs may be insuffi-
cient to assess depression. Self-report, or a clinician-
administered observer-rated scale for those with mod-
erate to severe dementia, has been recommended for
assessment of depression in nursing home residents
[81]. The MDS 3.0 takes this approach with the em-
bedded Patient Health Questionnaire-9 Observational
Version designed for residents unable to self-report
based on observations [82]. It is completed by trained
nurse assessors through interview with a caregiver
who knows the resident, thus combining clinician ex-
pertise with caregiver knowledge of the resident. The
Patient Health Questionnaire-9 Observational Version
demonstrated strong correlation (r = 0.84, n = 48) with
trained research nurse-administered CSDD [83].
We included studies conducted in all settings and
some measures therefore require further validation in
long-term care settings. Where measures do not exist
for symptom assessment in long-term care, this review
informs selection of measures for further validation by
reporting strength of psychometric properties and po-
tential applicability in long-term care settings.
This systematic review identifies and critically ap-
praises measures of common symptoms in the dementia
population in long-term care; however, there are a num-
ber of limitations. Screening measures are used to detect
diagnoses such as depression and anxiety. Studies evalu-
ating screening measures may not have been detected or
met the inclusion criteria for this study. Furthermore,
the quality criteria used in this review were not devel-
oped to evaluate screening tools. However, using the
same quality criteria provided consistency of appraisal
across the included measures. We limited the study to
English language-validated measures only and to publi-
cations in English only. This means measures not devel-
oped in English, such as the Dutch Rotterdam Elderly
Pain Observation Scale [84], or translated measures,
such as the German [85, 86] and Chinese [87] versions
of the PAINAD, and Dutch [88, 89] and Italian [90] ver-
sions of the DS-DAT, are excluded. We recognize that
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the conclusions are therefore limited to English language
measures and therefore limited to English-speaking pop-
ulations and cultures, with the majority of studies con-
ducted in English-speaking countries, predominantly the
United States. This means that the most established
measures with the strongest international psychometric
evidence that have been validated in multiple languages,
countries, or cultures are not identified as such. Finally,
decisions regarding whether measures met the inclusion
criteria required judgement at times. To improve object-
ivity, those full-texts that did not clearly meet the exclu-
sion criteria were second reviewed and a decision
reached by consensus.
Conclusion
Assessment measures of pain are the best developed and
have the strongest evidence of psychometric properties
for use by caregivers in people with dementia. All other
assessment measures require further evaluation when
administered by caregivers in long-term care settings. A
caregiver-completed multi-symptom measure to assess
the full extent of symptoms in people with dementia is ur-
gently required so that symptoms are detected and resi-
dents are referred when medical intervention is needed.
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